Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Dissolution Testing in Pharma - From Development to Regulatory Approval" training has been added to ResearchAndMarkets.com's offering. Dissolution ...

Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, analysts must understand ...

Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Dissolution Market - A Global and Regional Analysis: Focus on Type, End User, and Region - Analysis and Forecast, 2024-2033" has been ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...

The British Pharmacopoeia on Monday released its response to its consultation on dissolution testing and announced its plans to update its approach within its product monographs. The British ...

The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...

Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry, as well as an experienced provider of validation and qualification services, ...

Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...

To achieve reliable and reproducible results, analysts must understand the importance of correct equipment set-up, sample introduction and sampling. In addition to use of dissolution testers, this ...

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining ...